Siliceous Or Calcareous Material (e.g., Clay, Earth, Etc.) Patents (Class 514/770)
-
Publication number: 20100092564Abstract: An improved orally dissolving tablet (ODT) and method of manufacture is provided. The improved ODT disclosed herein are prepared by direct compression of a mixture of pharmaceutical excipients including at least one water-insoluble hydrophobic inorganic salt in combination with at least one water-insoluble inorganic salt with less hydrophobicity compared to the water-insoluble hydrophobic inorganic salt component. These components may be formed into granules, and may include other commonly used excipients. In an illustrative embodiment, the granules are formed into tablets by direct compression, optionally using a lubricant. The fast disintegrating tablets prepared using these components exhibit desirable performance properties such as sufficient hardness, low friability, quick disintegration time and good mouth-feel when compared to conventional ODT. A further advantage is that the improved ODT may be manufactured using commonly available manufacturing equipment for granulation, blending and tableting.Type: ApplicationFiled: December 20, 2007Publication date: April 15, 2010Inventors: Jae Han Park, Stephen H. Wu, Kevin M. Holman, Cliff J. Herman
-
Publication number: 20100092525Abstract: A medical device for delivery of a therapeutic agent to a physiological target site includes a flexible receptacle containing said therapeutic agent, wherein at least a part of the receptacle is formed of a water-soluble or water-dispersible material. The therapeutic agent may include a haemostatic agent and the physiological target site may be a wound.Type: ApplicationFiled: November 16, 2007Publication date: April 15, 2010Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Julian Hardy, Stewart Andrew Darby, Andrew Guy Eason
-
Publication number: 20100087548Abstract: The present invention relates to a method of formulating a liquid dual phase cosmetic or pharmaceutical composition in which the phases are separate before and after being mixed, the method comprising combining an aqueous phase and an oil phase, wherein one of the aqueous and oil phases has incorporated therein, as a demixing agent, an effective amount of a non-cationic film forming agent such as polyvinylpyrrolidone and copolymers thereof. The compositions of the invention are particularly useful as makeup removers.Type: ApplicationFiled: December 8, 2009Publication date: April 8, 2010Inventors: Linda Najdek, Derron T. Peck, Elena M. Ciriello, Ralph Vitale
-
Publication number: 20100075851Abstract: A dosage form with a sustained release rate for water-soluble and/or water-insoluble substances, such as fertilizers and/or nutrients and/or protecting agents for plants, animals and microorganisms in aquacultures, characterized in that said substances are incorporated individually or in the form of mixtures with one another in a finely divided form in a support insoluble in water, from which they are released in defined amounts over time at a highly reduced rate, the support being an elastomer cross-linked by high energy radiation.Type: ApplicationFiled: January 22, 2008Publication date: March 25, 2010Inventor: Phillip Mertens
-
Publication number: 20100068291Abstract: The invention relates to oral medicaments having a modified release of proton pump inhibitors (PPI's) that are, in particular, useful in preventing and treating gastrointestinal disorders. The aim of the invention is to provide a novel oral medicament based on PPI's ideally having all or some of the following characteristics: a) quickly providing relief to the patient by increasing the gastric pH after oral administration of the medicament; b) accelerating the recovery of patients while maintaining this increase in the gastric pH for as long as possible after oral administration of the medicament and, in particular, during the night; c) improving the observance of the treatment and the comfort of the patient by taking the medicament once daily.Type: ApplicationFiled: May 15, 2006Publication date: March 18, 2010Applicant: FLAMEL TECHNOLOGIES, S.A.Inventors: Philippe CAISSE, Catherine CASTAN, Rémi MEYRUEIX, Gérard SOULA
-
Publication number: 20100040678Abstract: The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator.Type: ApplicationFiled: September 25, 2007Publication date: February 18, 2010Inventors: Michael Ambuhl, Jutta Beyer, Begona Carreno-Gomez, Colleen Ruegger, Stephen Valazza
-
Publication number: 20100040701Abstract: A novel exfoliating compound and method for treating acne without an irritating cleanser. The compound includes a first subcompound formed from a clay based substance and a second subcompound formed an exfoliating substance selected from the group consisting of crystals, beads, polyethylene, nuts, natural rough products, corundum crystals, crushed almond shells and crushed apricot kernels.Type: ApplicationFiled: August 10, 2009Publication date: February 18, 2010Inventor: Neal Schwartz
-
Publication number: 20100029486Abstract: Provided are cap layer compositions and base layer compositions, providing quick and extended release of an active ingredient, respectively, when placed in water. Further provided are dual release compositions including a base composition and a cap composition. The base composition may include a plaster and an active agent, and it may further include at least one of a water-soluble binder, a non-water-soluble binder, and a lubricant. The cap composition may include a plaster and an active agent, and it may further include at least one of a disintegrating agent, a non-water-soluble binder, and a lubricant. The compositions may be heated and mixed and formed into a tablet. Further provided are methods of making the compositions. Further provided are methods of controlling or eliminating pests and methods of increasing the potability of water. The compositions are effective for controlling or eliminating pests such as mosquitoes when applied at an application site.Type: ApplicationFiled: July 31, 2009Publication date: February 4, 2010Inventors: Michael Dean Willis, Marie Elizabeth Saunders
-
Publication number: 20100021565Abstract: The present invention relates to pearlescent pigments based on flake-form substrates which have at least one FeOOH layer and at least one TiO2 layer or at least one TiO2/SiO2/TiO2 layer package, and to the use thereof, inter alia, in paints, coatings, printing inks, powder coatings, plastics and in particular in care and decorative cosmetics.Type: ApplicationFiled: December 12, 2007Publication date: January 28, 2010Applicant: MERCK PATENT GMBHInventors: Carsten Handrosch, Marcus Mathias, Nicole Schupp, Meike Willius
-
Publication number: 20100022439Abstract: The present invention provides an improved method of loading silica nanostructures with an active agent, comprising exposing a mixture comprising a liquid medium containing an active agent and silica nanostructures to reduced air pressure for a time period, and then returning the mixture to atmospheric air pressure at the end of the time period.Type: ApplicationFiled: June 15, 2009Publication date: January 28, 2010Applicant: PURDUE PHARMA L.P.Inventor: Paul R. Blake
-
Publication number: 20100016448Abstract: There is provided granules for the production of flash-melt pharmaceutical oral dosage forms. In addition to one or more medicaments, the granules are composed of an excipient combination consisting of a superdisintegrant, a dispersing agent, a distributing agent, and a binder and may also include other conventional ingredients such as sweetening and flavoring agents. The subject granules are advantageous in that they are stable and can be prepared without the aid of solvents and without the need for special environments or handling. Dosage forms, especially tablets, prepared therefrom on conventional equipment disintegrate in the mouth in under about twenty five seconds.Type: ApplicationFiled: September 14, 2009Publication date: January 21, 2010Inventors: SANJEEV KOTHARI, DIVYAKANT S. DESAI
-
Publication number: 20100010101Abstract: The present invention provides a novel rapid-melt pharmaceutical composition comprising a binder, a super emulsifier, a diluent/bulking material; and an active ingredient. The present invention also provides a rapid-melt bead composition comprising a binder having a melting point from about 20 to about 90° C., an emulsifier; a diluent/bulking material; and an active ingredient. Further, the present invention provides a chew tablet composition comprising a binder; an emulsifier having a melting point of greater than about 40° C.; a diluent/bulking material; and an active ingredient. Methods of making the disclosed compositions are also described.Type: ApplicationFiled: July 13, 2009Publication date: January 14, 2010Applicant: Capricorn Pharma, Inc.Inventor: S. Rao Cherukuri
-
Publication number: 20100010050Abstract: There have been found novel compositions for the controlled release of agrochemical active substances, containing at least one agrochemical active substance, cellulose ester and calcium carbonate.Type: ApplicationFiled: August 17, 2007Publication date: January 14, 2010Applicant: Bayer CropScience AGInventors: Karl Reizlein, Horst Gruttmann, Jürgen Thomzik, Joachim Krüger
-
Patent number: 7638144Abstract: A composition including a base and a plurality of abrasive particles. An apparatus including a head, and an applicator coupled to the head, the applicator having dimensions suitable for contacting localized areas of human skin. A method including applying a composition to an area of human skin, the composition comprising a base and a plurality of abrasive particles, and manipulating the composition over the area of human skin with a handle-operated instrument.Type: GrantFiled: March 9, 2001Date of Patent: December 29, 2009Assignee: DermaNew, Inc.Inventor: Dean Rhaodes
-
Publication number: 20090312439Abstract: The use of Schülpen based on pyrogenically produced silicon dioxide in pharmaceutical compositions, the pharmaceutical compositions per se, as well as an adsorbate consisting of the Schülpen and at least one further substance selected from pharmaceutical active constituents and excipients, and the produce of such adsorbates, are described.Type: ApplicationFiled: May 10, 2006Publication date: December 17, 2009Inventors: Ralph Hofmann, Ann Gray, Margarete Drechsler
-
Publication number: 20090304795Abstract: The present invention relates to a method for the preparation of pharmaceutical compositions in the form of tablets with improved drug substance dispersibility, which method comprises a) preparing a dispersion of at least one pharmaceutically active drug substance and at least one surfactant and/or binder in a liquid; b) preparing a carrier by dry blending at least one porous carrier and one or more excipient(s); and c) spray granulating the dispersion prepared in step a) onto the carrier prepared in step b) to obtain a spray-granulated product.Type: ApplicationFiled: August 17, 2009Publication date: December 10, 2009Inventors: Nathalie Bernigal, Eric Garcia, Susanne Page, Joseph Tardio
-
Publication number: 20090306224Abstract: The use of Schülpen based on pyrogenically produced silicon dioxide in pharmaceutical compositions is described.Type: ApplicationFiled: May 10, 2006Publication date: December 10, 2009Applicant: DEGUSSA GMBHInventors: Ann Gray, Margarete Drechsler, Ralph Hofmann
-
Publication number: 20090298952Abstract: Edible colored powders are formed by combining silica with a soluble dye, such as a natural dye. The colored powders can be used to color edible substrates such as particles and compressed tablets. Methods of forming the edible colored powders may include a drying step to reduce the moisture content of the colored powder.Type: ApplicationFiled: May 7, 2009Publication date: December 3, 2009Inventors: Karen S. Brimmer, Penny F. Martin
-
Publication number: 20090280147Abstract: According to the invention, a cosmetic composition is provided comprising: (a) amorphous particles, each amorphous particle comprising a homogeneous distribution of one or more dyes encapsulated by an amorphous, siliceous encapsulating agent, wherein the amorphous particle comprises from 3% to 20%, preferably 5% to 15%, more preferably 8% to 12% dye, by weight of the particle; (b) a cosmetically acceptable carrier.Type: ApplicationFiled: August 12, 2008Publication date: November 12, 2009Inventors: Peter Carl Anders Alberius, Robert William Corkery, Alison Fiona Stephens
-
Publication number: 20090269374Abstract: The present invention provides a cosmetic composition including oil phase ingredients 40-90% by weight and powder ingredients 10-60% by weight. The oil phase ingredients include volatile oil 5-70 parts by weight and dimethicone/vinyl-dimethicone crosspolymer 0.1-5 parts by weight. The powder ingredients include organic hectorite 0.5-40 parts by weight, methyl methacrylate crosspolymer 0.5-5 parts by weight, and pulverulent body 0.5-50 parts by weight.Type: ApplicationFiled: August 9, 2006Publication date: October 29, 2009Applicant: STC Nara Co., Ltd.Inventors: Kye-Ho Lee, Jong-Hwan Kim, Sung-Ho Chung
-
Publication number: 20090239957Abstract: One aspect of the present invention relates to stabilized irrigating compositions comprising sodium glycerophosphate and/or calcium glycerophosphate, and a bicarbonate salt. Another aspect of the present invention relates to methods of irrigating ocular tissues during a surgical procedure comprising bathing the intraocular tissues with an irrigating composition comprising sodium glycerophosphate and/or calcium glycerophosphate, and a bicarbonate salt.Type: ApplicationFiled: December 19, 2008Publication date: September 24, 2009Applicant: ALCON RESEARCH, LTD.Inventors: Mandar V. SHAH, Joseph Paul BULLOCK, Alan L. WEINER, Harli DOLLINGER, Simaben B. PATEL
-
Publication number: 20090232887Abstract: A pharmaceutical paste composition comprising an active ingredient such as an addictive substance, a controlled release agent, and a pharmaceutically suitable aqueous or non-aqueous carrier. The composition may comprise one or more of a clay, or an oily, waxy, or fatty substance. The composition may be filled into a capsule or other dispensing device. The composition may reduce dose dumping of an active ingredient. Methods of making and using the composition are also described.Type: ApplicationFiled: May 14, 2007Publication date: September 17, 2009Inventors: Isa Odidi, Amina Odidi
-
Publication number: 20090226385Abstract: A cosmetic composition comprising: (a) an aqueous and/or oil phase comprising: (i) water, and (ii) at least one cosmetically active ingredient; (b) a coupling agent; and (c) an oil phase comprising: (i) an isoparaffin solvent, and (ii) a silicone-containing solvent having the formula:Type: ApplicationFiled: March 7, 2008Publication date: September 10, 2009Inventors: Wenning Wang Han, James Zielinski, Bernie J. Pafford
-
Publication number: 20090221717Abstract: This invention relates to a cement, which comprises in its main phase of microcrystalline magnesium ammonium phosphate and nanoapatite after hardening and thus at the same time has considerable strength. The material is biologically degradable and is suitable for application in tooth cements, as bone replacement, as bone filler, as bone cement or as bone adhesive.Type: ApplicationFiled: May 11, 2009Publication date: September 3, 2009Applicant: KYPHON SARLInventor: Michael Zimmermann
-
Publication number: 20090220475Abstract: The bone repair material comprises the following components: A) a first granular component with a diameter larger than 20 ?m chosen from the group of: calcium phosphate, calcium pyrophosphate, or calcium sulfate dihydrate; B) a second component chosen from the group of apatite powder with a particle diameter smaller than 1 ?m, (preferably smaller than 100 nm); and B) a third component comprising water or an aqueous solution, whereby C) the volume fraction of the second and third component represents at least 35 volume-% of the total bone repair material.Type: ApplicationFiled: November 15, 2005Publication date: September 3, 2009Applicants: DR. H.C. ROBERT MATHYS STIFTUNG, SYNTHES GMBHInventors: Marc Bohner, Andrea Montali, Yvonne Bruderer
-
Publication number: 20090214447Abstract: The present invention is directed to cationic nanoparticles, methods to make them, and the use of compositions containing said nanoparticles in personal care compositions or formulations. The nanoparticles are useful in personal care applications and impart antimicrobial properties to home and personal care products containing them. These cationic nanoparticles also contribute useful conditioning properties to hair-care and skin-care products.Type: ApplicationFiled: February 17, 2009Publication date: August 27, 2009Inventors: John Jennings, Dietmar Haglin, Jianwen Mao, Andreas Muhlebach
-
Publication number: 20090215808Abstract: Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.Type: ApplicationFiled: December 5, 2008Publication date: August 27, 2009Inventors: Su Il Yum, Wendy Chao, Huey-Ching Su, Roger Fu, Michael Zamloot
-
Publication number: 20090197972Abstract: The present invention relates to an X-ray amorphous-crystalline material with high solubility which can be used as a bioactive bone replacement material and as a substrate material in biotechnology. The new material comprising crystalline and X-ray amorphous phases is characterized in that according to 31P-NMR measurements, it contains Q0-groups of orthophosphate and Q1-groups of diphosphate, the ortho-phosphates or Q0-groups making up 70 to 99.9% by weight relative to the total phosphorus content of the finished material and the diphosphates or Q1-groups making up 0.1 to 30% by weight relative to the total phosphorus content of the finished material, and that according to X-ray diffractometric measurements and relative to the total weight of the finished material, 30 to 99.9% by weight of a main crystal phase consisting of Ca2K1?xNa1+x(PO4)2, where x=0.1 to 0.9, is contained in the bone replacement material and 0.Type: ApplicationFiled: April 15, 2009Publication date: August 6, 2009Applicant: BAM BUNDESANSTALT FUER MATERIALFORSCHUNG UND PRUEFUNGInventors: Georg BERGER, Andrea SPITZER, Christian JAGER, Jutta PAULI, Renate GILDENHAAR
-
Publication number: 20090192205Abstract: A process for the release of a biologically active species comprising the steps of: providing a mesoporous oxide-based material having structural order and at least one level of porosity; fixing or immobilizing said biologically active species in said ordered mesoporous oxide; and providing said ordered mesoporous oxide with said fixed or immobilized biologically active species in vivo thereby realizing intraluminally induced substantially pH-independent supersaturation of said biologically active species resulting in enhanced transepithelial transport; wherein said biologically active species is a poorly soluble therapeutic drug classified as belonging to Class II or Class IV of the Biopharmaceutical Classification System and said ordered mesoporous oxide has a pore size in the range of 4 to 14 nm.Type: ApplicationFiled: January 28, 2009Publication date: July 30, 2009Applicant: Katholieke Universiteit Leuven K.U. Leuven R&DInventors: Patrick AUGUSTIJNS, Johan Adriaan Martens, Randy Mellaerts, Guy Van Den Mooter
-
Publication number: 20090192513Abstract: Ceramic precursor compositions and chemically bonded ceramic (CBC) materials, especially Ca-based, and a composite biomaterial suitable for orthopaedic applications. The CBC-system includes a binding phase (chemical cement) and additional phases with specified chemistry imparting to the biomaterial the ability of initial strength followed by interaction with the body tissue including body liquid, to form a resorbable or partly resorbable biomaterial. The ceramic precursor composition includes at least one silicate with Ca as the main cation with a resorption rate less or equal to that of the bone in-growth rate. The silicate will form the binding phase of the cured material. Implants and surface coated devices are also disclosed. The cured material exhibits a compressive strength exceeding 100 MPa.Type: ApplicationFiled: April 3, 2009Publication date: July 30, 2009Inventors: Leif Hermansson, Hakan Engqvist
-
Publication number: 20090186081Abstract: A disintegrating loadable tablet product in compressed form comprising i) at least 60% w/w of a sorbent material having a specific surface area (BET surface area) of at least 50 m2/g as measured by gas adsorption or mixtures of such sorbent materials, and ii) a disintegrant or a mixture of disintegrants wherein the tablet in compressed form has a) a porosity of 45% v/v or more, b) a hardness of at least 20 Newton, and c) a loading capacity of at least 30% of a liquid. The tablet is suitable for the preparation of a tablet containing an active substance by e.g. immersing the tablet in a liquid containing the active substance. The invention thus provides a safe and reproducible new method of preparing pharmaceutical tablets.Type: ApplicationFiled: January 5, 2007Publication date: July 23, 2009Applicant: LifeCycle Pharma A/SInventors: Per Holm, Lillian Slot
-
Publication number: 20090177273Abstract: The present invention relates to a process for fabricating a porous coatings with controlled structure in the micro and nano-size domain. In particular, but not exclusively, it relates to a process for fabricating coatings with an anisotropic pore size distribution and to coatings obtained using such coatings. It describes in particular the use of ink-jet method to deposit in a controlled way such coatings. It also relates to porous coatings with controlled structure in the micro and nano-size domain. The coating has a thickness between 10 nanometers and 10 millimeters and its porosity is created in such a way that the pore size distribution is anisotropic. It finally describes objects covered with this coating.Type: ApplicationFiled: May 16, 2007Publication date: July 9, 2009Inventors: Laurent-Dominique Piveteau, Heinrich Hofmann, Frederic Neftel
-
Publication number: 20090170705Abstract: Novel seed dressing agent formulations comprising of—at least one active agrochemical ingredient for the dressing of seeds, —a dispersion of biologically degradable polyester-polyurethane-polyureas in water whereby the solid content thereof is between 30 and 50 weight %. Said formulation also comprises additives. The invention also relates to a method for the production of a novel seed dressing agent formulation and the utilization thereof for the dressing of seeds.Type: ApplicationFiled: January 12, 2007Publication date: July 2, 2009Applicant: Bayer Technology Services GmbHInventors: Arno Nennemann, Johan Kijlstra, Daniel Rudhardt, Frank Sicking
-
Publication number: 20090155356Abstract: The present invention relates to a novel thixotropic oily vehicle comprising between about 0.2% to about 5% (w/w) of a colloidal silica and between about 0.2% to about 5% (w/w) of a hydrophilic polymer in an edible oil. The interaction between the hydrophylic polymer and the colloidal silica in the above concentration ranges confers thixotropy and a low viscosity under shear on the solution. The invention also relates to capsules filled with the above thixotropic solution used as a fill mass.Type: ApplicationFiled: February 18, 2009Publication date: June 18, 2009Inventor: Martin Kuentz
-
Publication number: 20090149553Abstract: An injectable resorbable bone graft material, and methods of using the same, provide increased compressive strength after injection in a bone defect. The bone graft material is made from calcium sulfate hemihydrate having a thick stubby rod-like crystalline structure and low water-carrying capacity.Type: ApplicationFiled: February 17, 2009Publication date: June 11, 2009Inventors: Jantzen A. Cole, Michael E. Carroll, Jon P. Moseley, Kelly C. Richelsoph
-
Publication number: 20090137688Abstract: The present invention relates to a pharmaceutical product comprising porous silicon, a beneficial substance, and an excipient, the beneficial substance being located in at least some of the pores of the porous silicon, and the excipient having a structure and composition such that it has a melting point between 25 C and 45 C. The invention allows improved control over the release of a beneficial substance from porous silicon.Type: ApplicationFiled: December 6, 2006Publication date: May 28, 2009Inventor: Hongli Yang
-
Publication number: 20090131949Abstract: Calcium-strontium-hydroxyphosphate (strontium-apatite-) cement preparations are described, comprising a powder mixture, which contains molar quantities of the components calcium (Ca), strontium (Sr) and phosphate (P) in the mixture in the ranges 1.00<Ca/P?1.50 and 0<Sr/P<1.5, together with an alkali salt or an ammonium salt of phosphoric acid, and with water and/or an aqueous solution. The powder mixture particularly contains, as the Ca-component, Ca3(PO4)2 (TCP), and as the Sr-component SrHPO4 and/or Sr3(PO4)2 and optionally additional SrCO3. As the aqueous mixing solution for the formation of the strontium-apatite cement, an aqueous solution of an alkali salt or an ammonium salt of the phosphoric acid is suitable.Type: ApplicationFiled: January 26, 2009Publication date: May 21, 2009Applicant: WARSAW ORTHOPEDIC, INC.Inventor: Robert WENZ
-
Publication number: 20090124536Abstract: A bone implant composition, the composition comprising calcium sulphate and slowly soluble source of calcium, orthophosphate and hydroxyl ions. The composition may be provided in powder or granulated form.Type: ApplicationFiled: January 20, 2009Publication date: May 14, 2009Applicant: Biocomposites LimitedInventor: JOHN JOSEPH COOOPER
-
Publication number: 20090120339Abstract: The present inventions generally relate to compositions and methods for providing agricultural chemicals comprising active ingredients (A.I.s) combined with a top dressing for application to cultivated areas of turfgrass. Specifically, the compositions are in the form of moist formulations for providing top dressings comprising active ingredients. Further, the inventions relate to compositions and methods for delivering active ingredients simultaneously with a top dressing composition to golf course turf.Type: ApplicationFiled: October 17, 2008Publication date: May 14, 2009Inventors: A. Ronald Detweiler, Nancy M. Dykema, Joseph M. Vargas, JR.
-
Publication number: 20090104263Abstract: A solid pharmaceutical composition for oral administration comprising tegaserod in base or salt form in an amount of up to 10% by weight a bulking agent in an amount of 70 to 90% by weight a disintegrant in an amount of less than 15% by weight a glidant and a lubricant,Type: ApplicationFiled: October 7, 2008Publication date: April 23, 2009Inventors: Jerome Aubert, Christian Vitzling
-
Publication number: 20090093364Abstract: A resin composition containing an agricultural chemical in which the release of an agricultural chemical active ingredient is controlled; a production method thereof; and an agricultural chemical formulation; in other words, an agricultural chemical-containing resin composition which is a composition containing an agricultural chemical active ingredient, a resin, and a fatty acid metal salt, and characterized in that the composition is either in a compatible state or forming a matrix; its production method; and an agricultural chemical formulation including at least one of the agricultural chemical-containing resin compositions; in addition to an agricultural chemical-containing resin composition which is a composition containing an agricultural chemical active ingredient, a (meth)acrylate based resin, and a release controlling agent, and characterized in that the composition is either in a compatible state or forming a matrix; its production method; and an agricultural chemical formulation including at leastType: ApplicationFiled: February 2, 2007Publication date: April 9, 2009Inventors: Yoshihisa Endo, Satoru Yamamura, Yuichi Maekawa
-
Publication number: 20090076173Abstract: A delivery system for a hygienic agent according to the present invention includes an agent in a viscous paste and/or semi-solid gel form, which includes a skin benefiting composition containing cleansing and/or positive skin sensory elements. The system is configured to deliver the skin benefiting composition to the whole body or on selected, discrete parts of the body to promote a skin massaging/pleasant feel, during either a washing process or outside of a washing process.Type: ApplicationFiled: April 19, 2007Publication date: March 19, 2009Inventors: Earl Philip Seitz Jr., E. Gary Myers, June Fine, John Salas, Jesus Macias
-
Publication number: 20090069447Abstract: A bright pigment with a gold tone of the present invention includes a scaly glass substrate 10, a base coating 20 containing at least one metallic material selected from the group consisting of silver, nickel and a nickel-based alloy, a gold coating 30 containing gold and a yellow coating 40 containing a yellow colorant and a parent material. The base coating 20, the gold coating 30 and the yellow coating 40 each form a layer covering the scaly glass substrate 10, and the base coating 20 is arranged innermost among the base coating 20, the gold coating 30 and the yellow coating 40.Type: ApplicationFiled: March 27, 2007Publication date: March 12, 2009Applicant: Nippon Sheet Glass Company, LimitedInventor: Takeaki Kitamura
-
Publication number: 20090062404Abstract: The present invention provides an intraoral rapid-disintegrating pharmaceutical composition which exhibits excellent intraoral disintegrating property and high hardness, and which can be applied, in particular, to a pharmaceutically active ingredient which is unstable in water. The pharmaceutical composition, which contains lactose and powdered cellulose, exhibits high hardness without prolongation of its intraoral disintegration time. When a disintegrating agent is further incorporated into the pharmaceutical composition, the hardness of the composition is increased without prolongation of its intraoral disintegration time. When magnesium aluminometasilicate, and one or more species selected from among silicic acid and silicic acid salts other than magnesium aluminometasilicate are further incorporated into the pharmaceutical composition, the composition exhibits higher hardness without prolongation of its intraoral disintegration time.Type: ApplicationFiled: February 28, 2006Publication date: March 5, 2009Applicant: Daiichi Sankyo Company, LimitedInventors: Yoshio Kuno, Hiroaki Nakagami
-
Publication number: 20090042950Abstract: At least one silicone is used to modify the release profile of the active compound(s) in a therapeutic composition for topical application the skin that also comprises at least one penetration enhancer and a fugitive solvent base.Type: ApplicationFiled: March 22, 2006Publication date: February 12, 2009Applicant: Transphase LimitedInventor: Anant K. Pandya
-
Publication number: 20090028922Abstract: This invention provides a rapidly degrading composition for local delivery of a medicament, such as, an antibiotic. Additionally, this invention provides a method that can be used on the battlefield to deliver antibiotics as a preliminary treatment through the use of a rapidly degrading composition.Type: ApplicationFiled: July 23, 2008Publication date: January 29, 2009Inventors: Warren O. Haggard, Kelly C. Richelsoph
-
Publication number: 20090030089Abstract: The invention is a silicon substituted oxyapatite compound (Si—OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca5(PO4)3-x(SiO4)xO(1-x)/2, where 0<x<1.0.Type: ApplicationFiled: October 3, 2008Publication date: January 29, 2009Applicant: Warsaw Orthopedic, Inc.Inventors: Michael Sayer, Joel Reid, Timothy J.N. Smith, Jason Hendry
-
Publication number: 20090016969Abstract: The present invention provides a formulation which contains a poorly water soluble pharmaceutically active compound at a concentration of 50 mg per 100 g formulation or above. The solubility is achieved by a mixture of solvents as described herein. Moreover the formulation as described herein may be used as a base formulation to generate a cream, an ointment, a spray, a foam or an oleogel.Type: ApplicationFiled: July 9, 2008Publication date: January 15, 2009Inventors: Hartwig STECKEL, Karin Hoffmann
-
Publication number: 20090018175Abstract: The present invention encompasses pharmaceutical excipient complexes comprising combining at least one carrier with an oily substance, and processes for preparing the same, stable pharmaceutical compositions comprising such complexes and active pharmaceutical ingredients and processes for preparing the same.Type: ApplicationFiled: April 25, 2008Publication date: January 15, 2009Inventors: Itamar Kanari, Michael Fox, Minutza Leibovici
-
Patent number: RE41279Abstract: The mastitis control teat dip composition having a visible indicator aspect of the invention provides a softening, soothing, smoothing, relaxing property, a rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition that is stable over an extended period of time, and unexpected long term microbial control when compared to the prior art materials disclosed in patents and used in the marketplace. The indicator aspect provides ease of visually detecting the material on the animal skin and can indicate efficacy of the material. The compositions of the invention are made by combining an aqueous liquid composition containing the visual indicator combined with the organic components which can be combined with a simple aqueous solution of a salt of chlorous acid, preferably an alkali metal chlorite.Type: GrantFiled: March 2, 2006Date of Patent: April 27, 2010Assignee: Ecolab Inc.Inventors: David D. McSherry, Francis L. Richter